Compounds > 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid
Page last updated: 2024-09-03

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and hydralazine

3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid has been researched along with hydralazine in 1 studies

Compound Research Comparison

Studies
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)		Trials
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)		Recent Studies (post-2010)
(3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid)		Studies
(hydralazine)		Trials
(hydralazine)		Recent Studies (post-2010) (hydralazine)
36114,580364393

Protein Interaction Comparison

ProteinTaxonomy3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid (IC50)hydralazine (IC50)
MyeloperoxidaseHomo sapiens (human)1.265
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)3.649
LactoperoxidaseBos taurus (cattle)1.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ksander, GM; Levens, NR; Mullane, KM; Zimmerman, MB1

Other Studies

1 other study(ies) available for 3-methyl-2-(3-pyridyl)-1-indoleoctanoic acid and hydralazine

ArticleYear
Thromboxane synthase inhibition enhances action of converting enzyme inhibitors.
    Hypertension (Dallas, Tex. : 1979), 1989, Volume: 13, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Drug Synergism; Hydralazine; Indomethacin; Kidney; Phenylacetates; Pyridines; Rats; Rats, Inbred SHR; Sulfonamides; Thromboxane-A Synthase

1989